Kimberly Gentile
Overview
Kimberly Gentile received an average of $3M in total compensation, including $350K in salary, at Biohaven Pharmaceutical Holding Co Ltd. between 2018 and 2019.
Source: SEC filings on March 20, 2020 and April 11, 2019.
Related executives
We found six more executives who work or worked at Biohaven Pharmaceutical Holding Co Ltd..
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
William Jones
Biohaven Pharmaceutical Holding Co Ltd.
Chief Commercial Officer of Migraine & Common Diseases
James Engelhart
Biohaven Pharmaceutical Holding Co Ltd.
Chief Financial Officer
Elyse Stock
Biohaven Pharmaceutical Holding Co Ltd.
Chief Medical Officer
Charles Conway
Biohaven Pharmaceutical Holding Co Ltd.
Chief Scientific Officer
John Tilton
Biohaven Pharmaceutical Holding Co Ltd.